NovelTRAF1-ALKfusion identified by deep RNA sequencing of anaplastic large cell lymphoma-Reference-Cited by-同舟云学术

NovelTRAF1-ALKfusion identified by deep RNA sequencing of anaplastic large cell lymphoma

Published:2013-09-02 Issue:11 Volume:52 Page:1097-1102
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Feldman Andrew L.¹,Vasmatzis George²,Asmann Yan W.³,Davila Jaime⁴,Middha Sumit⁴,Eckloff Bruce W.⁵,Johnson Sarah H.²,Porcher Julie C.⁶,Ansell Stephen M.⁶,Caride Ariel⁶

Affiliation:

1. Department of Laboratory Medicine and Pathology; Mayo Clinic; Rochester MN

2. Center for Individualized Medicine; Mayo Clinic; Rochester MN

3. Department of Health Sciences Research; Mayo Clinic; Jacksonville FL

4. Department of Health Sciences Research; Mayo Clinic; Rochester MN

5. Medical Genome Facility; Mayo Clinic; Rochester MN

6. Division of Hematology; Mayo Clinic; Rochester MN

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference18 articles.

1. A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines;Asmann;Nucleic Acids Res,2011

2. ALK-positive lymphoma: A single disease with a broad spectrum of morphology;Benharroch;Blood,1998

3. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders;Benner;Br J Dermatol,2009

4. Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells;Durkop;Blood,1999

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-Derived Antigenic Peptides as Potential Cancer Vaccines;International Journal of Molecular Sciences;2024-04-30

2. Detection of TRAF1‐ALK fusion in skin lesions of systemic ALK+ anaplastic large cell lymphoma initially involving the skin and the draining lymph node;The Journal of Dermatology;2023-09-27

3. Updates in pathobiological aspects of anaplastic large cell lymphoma;Frontiers in Oncology;2023-09-22

4. How molecular advances may improve the diagnosis and management of PTCL patients;Frontiers in Oncology;2023-06-23

5. Molecular Advances in Nodal Peripheral T-Cell Lymphoma;Advances in Molecular Pathology;2022-11